NCT00542373View on ClinicalTrials.gov

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

338

Participants

Timeline

Start Date

August 27, 2007

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
ErythroplakiaFanconi AnemiaLichen PlanusOral Cavity and Lip Precancerous ConditionOral Cavity LeukoplakiaOral NeoplasmPremalignant LesionTobacco Use Disorder
Interventions
OTHER

Cytology Specimen Collection Procedure

Undergo oral tissue collection

PROCEDURE

Diagnostic Microscopy

Mouth tissue examined microscopically for cytologic features

PROCEDURE

Diagnostic Procedure

Undergo standard white light headlamp oral examination

PROCEDURE

Fluorescence Imaging

Undergo widefield fluorescent and reflectance imaging

PROCEDURE

Fluorescence Spectroscopy

Undergo point fluorescent spectroscopy

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00542373 - Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer | Biotech Hunter | Biotech Hunter